Tus kws kho mob
P8-25 Update to Reimbursement Policy: Commercial General Coding 074 Cellular and Gene Therapy Product
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3111 - 3120 ntawm 4211
Tus kws kho mob
2025 February Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2025
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
Commercial Reimbursement Policy Intraoperative Neurophysiological Monitoring (IONM)
Tus kws kho mob
QP42-25 MHCP Pharmacy Benefit Exclusion for Encelto™ and Ryoncil®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 14, 2025
Tus kws kho mob
QP41-25 Commercial Pharmacy Benefit Exclusion for Encelto™, Epysqli® and Ryoncil®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 14, 2025
Tus kws kho mob
QP40-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 14, 2025
Tus kws kho mob
QP39-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 14, 2025
Tus kws kho mob
QP80R2-21 BlueRide announces No-Load Program for Non-Emergency Medical Transportation (NEMT) in Greater Minnesota
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 14, 2025